Sugi Predict

Sugi Predict / Compounds / SCHEMBL4339019

SCHEMBL4339019

SCHEMBL4339019

CN(C)[C@@H]1CCN(c2cc(N3CCN(c4ccc(Cl)c(Cl)c4)CC3)c(F)cc2/C=N/NC(N)=S)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.45
▸ ALDH1A1 P00352 7/20 0.45
▸ HTT P42858 4/20 0.45
▸ ALOX12 P18054 4/20 0.45
▸ LMNA P02545 3/20 0.45
▸ HPGD P15428 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ FPR1 P21462 2/20 0.37
▸ FPR2 P25090 2/20 0.37
▸ WDR5 P61964 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ HSD11B1 P28845 1/20 0.36
▸ NPY5R Q15761 2/20 0.36
▸ TDP1 Q9NUW8 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4339022 1.00 MAPT (0.45) MAPTALDH1A1HTTALOX12LMNA
SCHEMBL4327200 0.92 MAPT (0.43) MAPTALDH1A1HTTALOX12LMNA
SCHEMBL4327204 0.92 MAPT (0.43) MAPTALDH1A1HTTALOX12LMNA
SCHEMBL4329268 0.90 WDR5 (0.37) MAPTALDH1A1HTTALOX12LMNA
SCHEMBL4329273 0.90 WDR5 (0.37) MAPTALDH1A1HTTALOX12LMNA
SCHEMBL4331312 0.89 ALDH1A1 (0.46) MAPTALDH1A1HTTALOX12LMNA
SCHEMBL4331309 0.89 ALDH1A1 (0.46) MAPTALDH1A1HTTALOX12LMNA
SCHEMBL4331468 0.89 ALDH1A1 (0.46) MAPTALDH1A1HTTALOX12LMNA
SCHEMBL4331472 0.89 ALDH1A1 (0.46) MAPTALDH1A1HTTALOX12LMNA
SCHEMBL4327856 0.89 ALDH1A1 (0.37) MAPTALDH1A1HTTALOX12LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2009-11-19 — — US disclosed
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2009-11-19 — — US disclosed
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2009-11-19 — — US disclosed
US-7521062-B2 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) 2009-04-21 — — US disclosed
US-7521062-B2 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) 2009-04-21 — — US disclosed
US-7521062-B2 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) 2009-04-21 — — US disclosed
US-20050069555-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2005-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators MAVS, IRF3, HAVCR2 MAPT 3619/4885ALDH1A1 1459/4885HTT 2994/4885
US-20050069555-A1 Thiosemicarbazones as anti-virals and immunopotentiators MAVS, IRF3, HAVCR2 MAPT 3876/4885ALDH1A1 1173/4885HTT 3282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.